Evidence map›Paper›PMID 42751437›Full record

ArticleOncology letters2026

Seven-year follow-up demonstrating sustained survival following

Guangsheng Zhao, Xinyu Zhou, Shunhang Yin, Fang Xu, Licai Xu, Qiushi Wang, Jun Zhou, Song Liu

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Guangsheng ZhaoCancer Interventional Center, Affiliated Zhongshan Hospital of Dalian University, Dalian, Liaoning 116001, P.R. China.
Xinyu ZhouCancer Interventional Center, Affiliated Zhongshan Hospital of Dalian University, Dalian, Liaoning 116001, P.R. China.
Shunhang YinCancer Interventional Center, Affiliated Zhongshan Hospital of Dalian University, Dalian, Liaoning 116001, P.R. China.
Fang XuCancer Interventional Center, Affiliated Zhongshan Hospital of Dalian University, Dalian, Liaoning 116001, P.R. China.
Licai XuCancer Interventional Center, Affiliated Zhongshan Hospital of Dalian University, Dalian, Liaoning 116001, P.R. China.
Qiushi WangCancer Interventional Center, Affiliated Zhongshan Hospital of Dalian University, Dalian, Liaoning 116001, P.R. China.
Jun ZhouCancer Interventional Center, Affiliated Zhongshan Hospital of Dalian University, Dalian, Liaoning 116001, P.R. China.
Song LiuDalian Medical University, Dalian, Liaoning 116044, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lip squamous cell carcinoma is a distinct subtype of oral malignancy. Surgical resection provides satisfactory local tumor control; however, it frequently compromises oral function, diminishes local sensation and disfigures facial contour-sequelae are disproportionately debilitating in elderly patients with multimorbidity. This study reported the case of an 80-year-old woman with Alzheimer's disease who presented with locally advanced lip squamous cell carcinoma (cT3N2bM0, stage IVA) and cervical lymph node metastases. Following multidisciplinary team evaluation, the patient was deemed unsuitable for curative surgical resection or definitive external-beam radiotherapy. Therefore, computed tomography (CT)-guided radioactive

Indexed as

3D templatebrachytherapylip squamous cell carcinomalong-term survivaloral squamous cell carcinomaradioactive 125I seed implantation

Identifiers

PMID42751437
PMCPMC13579650

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.